Qulipta is used to prevent migraine attacks, but some people notice side effects when they stop taking it. Knowing a likely timeline and simple ways to handle symptoms can help patients who are discontinuing the drug. This article reviews common side effects, how long withdrawal symptoms typically last, and practical steps to make the transition smoother and less stressful.
Research also highlights uncertainty and limited evidence about stopping migraine preventive treatments.
Migraine Prophylaxis Discontinuation: Effects, Reasons & CGRP mAb Withdrawal There is limited strong evidence on how long prophylaxis remains effective and on what happens when therapy is stopped. This narrative review looks at the biological and clinical reasons clinicians may discontinue prophylactic therapy to inform decisions. Common reasons to stop include adverse events, lack of benefit, planned drug holidays after long-term use, and patient-specific factors. After stopping migraine prophylaxis, migraine burden may return to pre-treatment levels, stay the same, or fall somewhere in between. The current recommendation to stop CGRP(-receptor) targeted mAbs after 6 to 12 months is based on expert opinion rather than robust scientific data. Stopping migraine prophylaxis, L Al-Hassany, 2023
Common Qulipta Side Effects and How Long They Last
Qulipta can cause side effects that differ in how long they last and how severe they are. Many common effects ease within days to weeks, but the exact duration depends on the person and how long they used the medication.
Which side effects are most common with Qulipta?
People taking Qulipta often report several side effects, including:
Nausea: Often appears soon after starting and commonly lasts a few days.
Constipation: May develop over time and sometimes continues for weeks.
Decreased appetite: Appetite can drop and vary while on treatment.
Drowsiness: May occur at any point and can persist while taking the drug.
Fatigue: Common and may continue for a period after stopping Qulipta.
Dizziness: Can come and go, often lasting a few days.
Knowing these likely effects helps patients set expectations and plan for care during treatment.
Published studies give more detailed information on how often events like constipation and nausea happen with Qulipta.
Qulipta Withdrawal: Adverse Events & Side Effects (Constipation, Nausea) Main outcomes included changes from baseline in monthly migraine days and the incidence of adverse events (AEs) and treatment withdrawal due to AEs. There were no differences in the occurrence of AEs and drug withdrawal due to AEs between atogepant and placebo groups. Constipation was more commonly observed in patients treated with atogepant at 30 mg/day than placebo (RR 5.19, 95% CI 2.00–13.46;p= 0.001). Treatment with atogepant at the daily dose of 60 mg was associated with a higher risk of constipation (RR 4.92, 95% CI 1.89–12.79;p= 0.001) and nausea (RR 2.73, 95% CI 1.47–5.06;p= 0.001) than placebo. Atogepant for the prevention of episodic migraine in adults: a systematic review and meta-analysis of efficacy and safety, E Trinka, 2022
Withdrawal Timeline After Stopping Qulipta
The timing of withdrawal symptoms varies between people. Symptoms commonly begin within a few days of stopping and can last several weeks. Being aware of this window makes it easier to plan care and support.
How long do withdrawal symptoms usually last?
Most withdrawal symptoms last about 1 to 4 weeks. Symptoms often peak in the first week and then slowly ease. The dose and how long you took the drug can influence this timeline.
What are the typical withdrawal symptoms?
Common experiences after stopping Qulipta include:
Headaches: May occur as a rebound effect and can be severe for several days.
Nausea: Can return in a similar way to initial side effects.
Fatigue: Increased tiredness is common while the body readjusts.
Mood changes: Anxiety, irritability, or low mood can appear as the body adapts.
Being aware of these likely symptoms can help you seek timely support during withdrawal.
How to Safely Manage Qulipta Discontinuation and Side Effects
Stopping Qulipta should be planned with your healthcare provider. A personalised approach can lower the risk of withdrawal and make the process more comfortable.
What tapering schedule is recommended to reduce withdrawal symptoms?
A gradual taper is generally recommended. One practical approach is to reduce the dose by about 25% each week until a minimal effective dose is reached. This gives your body time to adjust and lowers the chance of more severe withdrawal.
Clinical experience supports gradual tapering to reduce discontinuation symptoms.
Qulipta Discontinuation Syndrome: Tapering for Withdrawal Qulipta Tab: 10, 30, 60 mg. Comment: Antidepressant-like discontinuation syndrome related to Qulipta may be reduced by tapering the dose gradually. Amp: 1 mg/ml (1 ml). Migranal: 1 spray in each nostril; may repeat after 15 minutes; maximum 6 sprays/day and 8 sprays/week, 2024
When should I seek medical help during withdrawal?
Contact your healthcare provider if withdrawal causes severe or worrying symptoms so they can assess you and offer appropriate treatment.
Persistent headaches: If headaches are severe or hard to control.
Severe nausea: If nausea prevents eating, drinking, or daily functioning.
Mood swings: If emotional changes are intense or you're concerned about safety.
Your clinician can recommend dose changes, short-term medications, or other supports to ease withdrawal.
Several approaches can reduce withdrawal symptoms. For details on tapering schedules, ask your healthcare professional or consult trusted clinical resources.
Strategy | Approach | Benefit |
Gradual Tapering | Reduce dose slowly over weeks | Lessens withdrawal severity |
Hydration | Drink fluids regularly | Helps with nausea and fatigue |
Nutritional Support | Eat a balanced diet | Supports recovery and energy |
The table summarises practical steps that can make withdrawal smoother and safer.
In short, understanding the likely timeline and side effects of Qulipta helps with planning and care. Recognise symptoms early and use safe discontinuation methods to support recovery.
Frequently Asked Questions
What are the signs that I should consult a healthcare provider during Qulipta withdrawal?
See a healthcare provider if you have severe or persistent symptoms such as headaches you can’t control, nausea that stops you eating or drinking, or major mood changes. Early contact lets your clinician adjust treatment and prevent complications.
How can I prepare for the withdrawal process from Qulipta?
Plan your stop with your provider and agree a tapering schedule. Keep a symptom diary to track changes, line up support from friends or family, and gather simple coping tools like hydration, small meals, and relaxation techniques. Planning ahead makes the process easier.
Are there alternative treatments for migraines after stopping Qulipta?
Yes. Options include other preventive medications, lifestyle changes, and complementary therapies such as acupuncture or cognitive behavioural therapy. Discuss alternatives with your clinician to find a plan that fits your history and migraine pattern.
What role does hydration play during the withdrawal from Qulipta?
Staying hydrated helps reduce nausea and fatigue and supports overall recovery. Aim for water, herbal teas, or electrolyte drinks if you’re losing fluids. Good hydration can improve energy and mood during withdrawal.
How can I differentiate between withdrawal symptoms and a migraine attack?
It can be hard to tell the difference. Withdrawal effects like fatigue and mood changes tend to appear soon after stopping and may be more persistent. Migraine attacks usually have clear signs like throbbing pain, light or sound sensitivity, and nausea. A symptom diary can help identify patterns to discuss with your provider.
What should I do if my withdrawal symptoms worsen over time?
If symptoms get worse, contact your healthcare provider right away. They can reassess your taper, suggest supportive treatments, or change your plan. Timely help can prevent complications and improve recovery.
What should I do if I experience severe withdrawal symptoms after stopping Qulipta?
If you have severe withdrawal symptoms, contact your healthcare provider immediately. Issues like persistent headaches, severe nausea, or major mood swings may need medical review. Your clinician can adjust the taper or suggest treatments to reduce discomfort and risk.
Can I stop taking Qulipta suddenly, or is tapering always necessary?
Stopping Qulipta suddenly is generally not recommended because it can increase withdrawal symptoms. A gradual taper is usually safer and reduces symptom intensity. Always discuss stopping the drug with your healthcare provider to create a plan that fits you.
Are there any long-term effects of discontinuing Qulipta?
Long-term effects vary. Some people may see migraine frequency or intensity return; others notice little change. Keep monitoring symptoms after stopping and stay in touch with your provider to address any issues that arise.
How can I manage nausea during the withdrawal phase?
To ease nausea, sip clear fluids and eat small, frequent meals rather than large ones. Ginger or peppermint can help some people. If nausea continues or worsens, seek advice from your healthcare provider for additional options.
Is it safe to use over-the-counter medications to relieve withdrawal symptoms?
OTC medicines can help, but check with your healthcare provider first. Some OTC options relieve headache or nausea but may interact with other drugs or affect side effects. Your clinician can recommend safe choices based on your health history.
What lifestyle changes can support my recovery after stopping Qulipta?
Support recovery with a balanced diet, regular gentle exercise, and good sleep. Relaxation practices such as yoga or meditation can help with anxiety. Staying hydrated and keeping a steady routine also aids overall recovery.
Purchase Your Over-the-Counter and Prescription Drugs From https://drugmart.com/ You can rely on https://drugmart.com/ for over-the-counter and prescription drugs at a discount. We're a leading referral service for patients who want to order medications from Canada online and other international partners, offering unparalleled customer service. If you have any questions, be sure to contact our outstanding customer service representatives for the answers you need.
Sources
Lattanzi, S., Trinka, E., Altamura, C., Giovane, C., Silvestrini, M., Brigo, F., … & Vernieri, F. (2022). Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety. Neurology and Therapy, 11(3), 1235-1252. https://link.springer.com/article/10.1007/s40120-022-00370-8
Puledda, F., Sacco, S., Diener, H., Ashina, M., Al‐Khazali, H., Ashina, S., … & Tassorelli, C. (2024). International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine. Cephalalgia, 44(9). https://journals.sagepub.com/doi/10.1177/03331024241269735
Na, J., Jeon, H., Shim, J., Lee, H., & Lee, Y. (2025). Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study. Brain Sciences, 15(5), 493. https://www.mdpi.com/2076-3425/15/5/493
